[1]郝晓甍,张瑾.血管内皮生长因子-C及其受体Flt4表达与乳腺癌临床病理状态及预后相关性研究[J].中华乳腺病杂志(电子版),2008,2(4):443-451.
点击复制

血管内皮生长因子-C及其受体Flt4表达与乳腺癌临床病理状态及预后相关性研究()

中华乳腺病杂志(电子版)[ISSN:1674-0807/CN:11-9146/R]

卷:
第2卷
期数:
2008年4期
页码:
443-451
栏目:
实验研究
出版日期:
2008-08-01

文章信息/Info

作者:
郝晓甍;张瑾
天津医科大学附属肿瘤医院乳腺科
关键词:
乳腺癌血管内皮生长因子-CFlt4淋巴结转移
摘要:
目的 研究血管内皮生长因子-C(VEGF-C)及其受体Flt4在乳腺癌中的表达及其表达程度与肿瘤临床病理特征及预后的关系。方法 收集手术切除后行石蜡包埋的乳腺癌标本60例,制作成4μm厚的连续切片,经免疫组织化学染色后观察乳腺癌组织中VEGF-C、Flt4的表达情况。结果 (1)乳腺癌细胞VEGF-C与其受体Flt4表达呈正相关(P<0.01);(2)VEGF-C与PCNA表达显著相关(P<0.01);(3)Flt4与增殖细胞核抗原(PCNA)表达显著相关(P<0.01);(4)淋巴结转移组乳腺癌细胞VEGF-C/Flt4阳性指数明显高于未转移组(P<0.05);(5)VEGF-C与患者年龄、肿瘤大小、组织学分级、ER、PR及病理类型无统计学关系(均P>0.05);(6)VEGF-C与预后无统计学关系。结论 VEGF-C/Flt4调控系统在乳腺癌细胞增殖中起一定的促进作用;VEGF-C/Flt4可能通过某种机制促进淋巴结转移;VEGF-C不能作为判断乳腺癌预后的独立指标。

相似文献/References:

[1]蒋宏传.乳腺癌根治术后乳房再造方法的选择[J].中华乳腺病杂志(电子版),2007,1(1):1.
 JIANG Hong-chuan.Selection of breast reconstlh_paperctive method after radical resection in breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):1.
[2]王永胜.乳腺癌前哨淋巴结活检研究进展[J].中华乳腺病杂志(电子版),2007,1(1):7.
 YANG Ming-tian,LIAN Zheng-qiang.Advancement of endocrine therapy in breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):7.
[3]杨名添,连臻强.乳腺癌内分泌治疗的进展[J].中华乳腺病杂志(电子版),2007,1(1):14.
 WANG Yong-sheng.Advancement of sentinel lymph node in breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):14.
[4]刘鹏熙,钟少文,陈前军.乳腺癌保乳术后背阔肌微肌瓣转移乳房整形[J].中华乳腺病杂志(电子版),2007,1(1):25.
 LIAN Peng-xi,ZHONG Shao-wen,CHEN Qian-jun.The use of a lastissimus doris miniflap for immediate correction of the deformity resulting from breast conservation surgery[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):25.
[5]王毅本,盛桦,曾小兵.乳腺癌术后引流液细胞学检查得临床价值[J].中华乳腺病杂志(电子版),2007,1(1):29.
 WANG Yi-ben,SHENG Hua,ZENG Xiao-bing.Examination of exfoliative cytology of draining liquid in patients with breast tumor[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):29.
[6]王水,刘晓安,赵佳.联合法观察前哨淋巴通道的临床研究[J].中华乳腺病杂志(电子版),2007,1(1):55.
 WANG Shui,LIU Xiao-an,ZHAO Jia.The study on sentinel lymphatic channels by using methylene blue and technetium 99m sulfur colloid in breast cancer patients[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):55.
[7]曾晓华,刘长安,邓建川.RNAi 抑制hTERT基因治疗乳腺癌的实验研究[J].中华乳腺病杂志(电子版),2007,1(1):61.
 ZENG Xiao-hua,LIU Chang-an,DENG Jian-chuan.Experimental research of targeting hTERT gene inhibited in breast cancer therapy by RNA interference[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):61.
[8]陈治,耿翠芝.植物雌激素与乳腺癌关系得研究进展[J].中华乳腺病杂志(电子版),2007,1(1):67.
 CHEN Zhi,GEGN Cui-zhi.Advancement of the relationship between phytoestrogen and breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):67.
[9]唐鹏,姜军.类固醇受体辅活化因子家族与乳腺癌[J].中华乳腺病杂志(电子版),2007,1(1):74.
 TANG Peng,JIANG Jun.steroid receptor coactivator family and breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):74.
[10]徐海滨,胡组健,胡望华.乳腺癌骨转移综合治疗初探[J].中华乳腺病杂志(电子版),2007,1(1):87.
 XU Hai-bin,HU Zu-jian,HU Wang-hua.Preliminary exploration of combined therapy in bone metastasis of breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):87.

更新日期/Last Update: 2008-01-20